Alyeska Investment Group’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,809,523
Closed -$8.38M 764
2025
Q4
$8.38M Sell
3,809,523
-1,838,848
-33% -$2.96M 0.02% 411
2025
Q3
$8.98M Buy
+5,648,371
New +$7.33M 0.03% 392
2025
Q1
Sell
-150,000
Closed -$309K 680
2024
Q4
$309K Hold
150,000
﹤0.01% 530
2024
Q3
$380K Hold
150,000
﹤0.01% 493
2024
Q2
$641K Hold
150,000
﹤0.01% 492
2024
Q1
$1.11M Buy
+150,000
New +$1.26M 0.01% 409

Other funds holding GUTS

Alyeska Investment Group's GUTS Position: Q1 2026 in Review

Alyeska Investment Group sold out of Fractyl Health (GUTS) in Q1 2026, closing a stake of 3,809,523 shares — an estimated $8.38M sold.

Alyeska Investment Group first reported a position in GUTS in Q1 2024 and held it in 6 quarters. The position peaked at $8.98M in Q3 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Alyeska Investment Group reported no remaining Fractyl Health position as of Q1 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 3,809,523 Fractyl Health shares in Q1 2026, an estimated $8.38M.
  • Alyeska Investment Group first reported a position in Fractyl Health in Q1 2024 and held it in 6 quarters.
  • Alyeska Investment Group's Fractyl Health position peaked at $8.98M in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.